Investor · San Francisco, CA

Steve Dow

Open Steve in the network graph →

Filings

17

SEC Form D

Connections

63

co-filers

Capital

$164.2M

across filings

Active

Apr 2009

to May 2021

Most-connected co-filers (63)

Asha Rajagopal · So. San Francisco, CA7 shared Wendye R. Robbins · South San Francisco, CA7 shared Corey Goodman · Suite 595, CA7 shared Chad Waite · Seattle, WA5 shared Esther Dyson · Mojave, CA4 shared Anne Wojcicki · Mountain View, CA4 shared Linda Avey · Woodside, CA4 shared Patrick S. Chung · CAMBRIDGE, MA4 shared Jesse Salk · Bellevue, WA4 shared Daniel O'Connor · Dublin, Ireland3 shared Sean O'Driscoll · Dublin, Ireland3 shared John O'Donnell · Dublin, Ireland3 shared Scott Minick · Framingham, MA3 shared Stephen Kingon · Dublin, Ireland3 shared Anne Maher · Dublin, Ireland3 shared John Axerio-Cilies · San Francisco, CA2 shared Ted Finkelstein · Poughkeepsie, NY2 shared Lawrence Loeb · Bellevue, WA2 shared Fabien Beckers · San Francisco, CA2 shared Robert Brownell · San Francisco, CA2 shared Jeffrey Lee · Hong Kong, Hong Kong1 shared Yan Ke · Hong Kong, Hong Kong1 shared Christopher Benoit · Branford, CT1 shared Holger W. Liepmann · Incline Village, NV1 shared

Recent filings (17)

TwinStrand Biosciences, Inc.May 2021 · 15 co-filers$50.0M TwinStrand Biosciences, Inc.May 2021 · 15 co-filers$50.0M DigitalOcean Holdings, Inc.May 2020 · 22 co-filers$50.0M DigitalOcean Holdings, Inc.May 2020 · 22 co-filers$50.0M TwinStrand Biosciences, Inc.Dec 2019 · 9 co-filers$16.3M TwinStrand Biosciences, Inc.Dec 2019 · 9 co-filers$16.3M TwinStrand Biosciences, Inc.Aug 2018 · 6 co-filers$4.0M TwinStrand Biosciences, Inc.Aug 2018 · 6 co-filers$4.0M Rubicon Markets Inc.Mar 2018 · 5 co-filers$15.0M Rubicon Markets Inc.Mar 2018 · 5 co-filers$15.0M Arterys IncNov 2017 · 11 co-filers$30.1M Arterys IncNov 2017 · 11 co-filers$30.1M TwinStrand Biosciences, Inc.Sep 2017 · 11 co-filers$5.5M TwinStrand Biosciences, Inc.Sep 2017 · 11 co-filers$5.5M Arterys IncDec 2015 · 7 co-filers$17.6M Arterys IncDec 2015 · 7 co-filers$17.6M 23andMe IncNov 2010 · 7 co-filers$27.8M 23andMe IncNov 2010 · 7 co-filers$30.0M 23andMe IncDec 2009 · 7 co-filers$27.8M KABIRA TECHNOLOGIES INCNov 2009 · 10 co-filers$3.0M KABIRA TECHNOLOGIES INCNov 2009 · 10 co-filers$3.0M LIMERICK BIOPHARMA INCAug 2009 · 11 co-filers$15.4M LIMERICK BIOPHARMA INCJul 2009 · 11 co-filers$15.2M LIMERICK BIOPHARMA INCJun 2009 · 9 co-filers$1.5M 23andMe IncMay 2009 · 7 co-filers$24.3M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Steve in the interactive graph →